FDA Orange Book
Is there a generic for Subvenite?
Subvenite contains lamotrigine. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Subvenite (lamotrigine). The Orange Book shows its last listed patent expires May 29, 2040.
Run it in Rivvi
Map Subvenite and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Subvenite products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| suspension, oral | 10MG/ML | Marketed (Rx) | None | 0 | None |
NDA 218879, held by OWP PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Subvenite patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 11596634 | May 29, 2040 | Method of use | U-4271 | 218879 |
| 11596634 | May 29, 2040 | Method of use | U-4272 | 218879 |
| 11596634 | May 29, 2040 | Method of use | U-4273 | 218879 |
| 11612566 | May 29, 2040 | Method of use | U-4271 | 218879 |
| 11612566 | May 29, 2040 | Method of use | U-4272 | 218879 |
| 11612566 | May 29, 2040 | Method of use | U-4273 | 218879 |
| 12629377 | May 29, 2040 | Drug product | U-4539 | 218879 |
| 12629377 | May 29, 2040 | Drug product | U-4540 | 218879 |
| 12629377 | May 29, 2040 | Drug product | U-4541 | 218879 |
| 12636289 | May 29, 2040 | Drug product | None | 218879 |
Subvenite NDC codes
Questions
Is there a generic for Subvenite?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Subvenite (lamotrigine). The Orange Book shows its last listed patent expires May 29, 2040.
What is the generic name for Subvenite?
The active ingredient in Subvenite is lamotrigine, per the FDA Orange Book.
When does the Subvenite patent expire?
The last patent listed for Subvenite in the Orange Book expires May 29, 2040. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.
More on Subvenite and Lamotrigine
- What is Lamotrigine used for?FDA label uses
- Is Lamotrigine a controlled substance?Federal schedule
- Generic for LamliqueFDA Orange Book
- Generic for Lamictal XRFDA Orange Book
- Generic for Lamictal CDFDA Orange Book
- Generic for Lamictal ODTFDA Orange Book
- Generic for LamictalFDA Orange Book
- Anti-epileptic Agents listFDA drug class
- Mood Stabilizers listFDA drug class
- NDC 69102-418Subvenite NDC record
- NDC 69102-150Subvenite NDC record
- NDC 69102-301Subvenite NDC record